HUMAN CHORIONIC GONADOTROPIN 1,250 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in w...
FDA Drug Recall #D-0237-2021 — Class II — November 20, 2020
Recall Summary
| Recall Number | D-0237-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 20, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Complete Pharmacy and Medical Solutions, LLC. |
| Location | Miami Lakes, FL |
| Product Type | Drugs |
| Quantity | 2400 vials |
Product Description
HUMAN CHORIONIC GONADOTROPIN 1,250 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035
Reason for Recall
CGMP deviations: Lack of potency testing.
Distribution Pattern
Distributed Nationwide in the USA
Lot / Code Information
Lot #: 40548, Use By Date, 01/30/2021.
Other Recalls from Complete Pharmacy and Medical Solutio...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0234-2021 | Class II | HUMAN CHORIONIC GONADOTROPIN 11,000 IU per vial... | Nov 20, 2020 |
| D-0235-2021 | Class II | HUMAN CHORIONIC GONADOTROPIN 6,000 IU per vial ... | Nov 20, 2020 |
| D-0236-2021 | Class II | HUMAN CHORIONIC GONADOTROPIN 5,000 IU per vial ... | Nov 20, 2020 |
Frequently Asked Questions
cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.